Tuesday 18th May 2021
Session 1, Chaired by Oliver Schubert
9:00 [UTC] Welcome address
9:15 Proteomic characterization of neuromelanin granules and substantia nigra in health and disease, Maximilian Wulf, Germany.
9:30 Identification and characterization of unknown subgroups of Parkinson patients, Daniel Kleefisch, Germany.
9:45 Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's Disease, Ioanna Markaki, Sweden
10:00 Synaptic proteome alterations in a rat model of progressive parkinsonism, Arantzazu Belloso-Iguerategui, Spain
10:15 MRM measurement of glucocerebrosidase activity and protein levels in CSF as biomarkers for Parkinson's disease, Patrick Oeckl, Germany
Session 2, Chaired by Katrin Marcus
10:45 [UTC] Identification of candidate biomarkers of Alzheimer Disease's by proteomics, Miren Alonso, Spain.
11:00 Smelling the dark proteome: Functional Characterization of PITH domain-containing protein 1 (C1orf128) in olfactory metabolism, Mercedes Lachen, Spain.
11:15 Identification of dysregulated proteins in Alzheimer's Disease that could be key for the understanding of the disease by quantitative proteomics, Ana Montero Calle, Spain.
11:30 Validation by biosensing approaches of new diagnostic biomarkers of Alzheimer Disease's identified by Phage Display and Protein Microarrays, Rodrigo Barderas, Spain.
11:45 Characterization of the olfactory tract proteostatic imbalance in Alzheimer's and Parkinson's diseases: cross-disease similarities and differences, Paz Cartas-Cejudo, Spain.
Session 3, Chaired by Robert McCullumsmith
13:15 Guest Talk: Atlas Antibodies
13:30 Guest talk: PreOmics
13:45 Proteomic Exploration of Microglia Behavior in the Presence of Brain Cancer, Iulia Lazar, USA.
14:00 Deciphering biomarkers by Comprehensive multipronged proteomics characterization of Cerebrospinal fluid from lep-tomeningeal metastasis in B-cell lymphoma, Manuel Fuentes, Spain.
14:15 Quantitative profiling of axonal guidance proteins during the differentiation of human neurospheres, Magno Junqueira, Brazil.
14:30 SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability, Victor Corasolla Carregari, Brazil.
Session 4, Chaired by Peter Nilson
15:00 [UTC] Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia, Giuliana Zuccoli, Brazil.
15:15 Complement and coagulation proteins in first episode psychosis: A proteomic insights from the OPTiMiSE cohort, Subash Susai, Ireland.
15:30 Parallel Microscopy, Proteomic, and Phosphoproteomic Analyses of Human Brain Tissue Identify Candidate Phosphorylation Events for Synaptic Pathology in Schizophrenia, Matthew MacDonald, USA.
15:45 The Effect of Clozapine on Adipose Tissue Cells, Aline Gazzola Fragnani Valença, Brazil.
16:00 Active kinome profiling in human brain substrates, Robert McCullumsmith, USA.
16:15 Closing remarks
Wednesday 19th May 2021
Session 5, Chaired by Melanie Föcking
9:00 [UTC} Welcome
9:15 Acute stress alters cerebellum metabolome, Aikaterini Iliou, Greece.
9:30 Altered IL-17 Pathway Changes in Autism Spectrum Disorder: A Systematic Review and Bioinformatic Analysis of Blood Based Biomarkers, Daragh O'Boyle, Ireland.
9:45 Autoantibodies in traumatic spinal cord injury and their impact on neuronal regeneration, Annika Guntermann, Germany.
10:00 Autoantibody profiles associated with clinical features in psychotic disorders (Part 1) - Technical aspects of exploring the autoimmune landscape, August Jernbom Falk, Sweden.
10:15 Autoantibody profiles associated with clinical features in psychotic disorders (Part 2) - Summary of findings, Oliver Schubert, Australia.
Session 6, Chaired by Charlotte Teunissen
10:45 [UTC] New bioinformatic approaches to get more out of your data, Julian Uszkoreit, Germany.
11:00 BIONDA: A free database for a fast information on published biomarkers, Michael Turewicz, Germany.
11:15 Morphine-induced Nfr-2 pathway modulation in primary human brain microvascular endothelial cells, Sandrine Reymond, Switzerland.
11:30 Proteomic profiling of human brain reveals the Inter-hemispheric laterality & Inter-regional expression, Deeptarup Biswas, India.
11:45 The brain sections of the human protein atlas, Jan Mulder, Sweden.
Session 7, Chaired by Daniel Martins-de-Souza
13:00 [UTC] Welcome back
13:15 TearProt - Characterization of tear fluid in patients with diabetes mellitus, Caroline May, Germany.
13:30 Systems-based examination of MAPK signaling in human stem cell derived retinal ganglion cells during cell death, Joseph Mertz, USA.
13:45 Exploring similar and different features of sporadic and familial ALS proteome, Viviana Greco, Italy.
14:00 Cerebrospinal fluid proteomics reveal altered protein levels in frontotemporal dementia, Sofia Bergström, Sweden.
14:15 Amyloid co-pathology in dementia with Lewy bodies is associated with a distinct cerebrospinal fluid proteomics profile Lisa Vermunt, Netherlands.
14:30 Closing remarks